(Q33372749)

English

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

heparin-induced thrombocytopenia

1 reference

based on heuristic

inferred from title

author name string

Freddy M Creekmore

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gary M Oderda

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Robert C Pendleton

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Diana I Brixner

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1438-1445

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A 14-year study of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.10.1438

21 January 2018

Identifiers

10.1592/PHCO.26.10.1438

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33372749&oldid=1631552775"